soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Updates in Medicine Oral Semaglutide and Cardiovascular Outcomes

Semaglutide suppresses hunger, but eating too little can trigger nutrient deficiencies, muscle loss, and metabolic slowdown

ShedRx provides virtual GLP-1 care with injections, drops, lozenges, brand-name options, and home delivery.

It typically presents as sudden, painless, monocular vision loss accompanied by optic disc edema

A clear comparison to help patients and professionals choose wisely.

A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide.

That is why current research focuses on improved delivery systems